Clinical Trial Update: Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind, placebo-controlled trial of semaglutide to prevent weight gain after liver transplantation in patients with Non-alcoholic fatt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: NAFLD | Phase 2 | Status: RECRUITING